Search

Search Constraints

You searched for: Author/Creator Fitzpatrick, Elizabeth

Search Results

2. Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer. (2nd September 2017)

3. Anti-HER2 CD4+ T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer. Issue 1 (December 2015)